View Cart (0 items)

Pharmaceutical

Pfizer Weighs Sale, Spin-off of Units

Chief Executive Officer Ian Read said he is reviewing the possible sale of four divisions with $18.3 billion in annual revenue, according to Bloomberg. Read, who took control of Pfizer
Read More

Linde Builds Large Hydrogen and Synthesis Gas Plant in China

Reuters reports, the Linde Group will build and operate a large hydrogen and synthesis gas plant in the Chongqing Chemical Park in Western China in a joint enterprise with Chongqing
Read More

A. Schulman Adds Manufacturing Line in Brazilian Facility

A. Schulman, Inc. announced that it will add one manufacturing line in its Sao Paulo, Brazil plant to accommodate increased demand for the company''s masterbatch and engineered plastics products, reports
Read More

J&J In Talks to Buy Swiss Company Synthes for $20 Billion

Reuters reports, Johnson & Johnson is in preliminary talks to acquire Swiss medical device maker Synthes for a price, which could be about $20 billion, a source familiar with the
Read More

GlaxoSmithKline to Invest £500 Million in Egypt Healthcare

Daily News Egypt reports, GlaxoSmithKline Consumer Healthcare announced they will invest approximately £ 500 million in Egypt’s healthcare sector. “Our main goal over the next five years is to
Read More

Pfizer Selling Capsugel Unit for $2.38 Billion

Reuters reports, Pfizer Inc has struck a deal to sell its Capsugel unit, the world''s largest maker of hard capsules, to private equity firm KKR & Co for nearly $2.38
Read More

Materia Plans Singapore-Based Catalyst Manufacturing Facility

In a press release, Materia announced its plans for opening a catalyst manufacturing and R&D facility in Singapore. The company expects to complete the site selection process in 3Q 2011
Read More

Bafna Pharma to Acquire Raricap from J&J

Pharmaceutical Business Review reports, Bafna Pharmaceuticals, a Chennai, India-based contract research manufacturer, plans to buy Raricap from Johnson & Johnson for INR210m. Raricap, which contains calcium, folic acid and iron,
Read More

Feds Takes Over Three Tylenol Plants

CNNMoney reports, the U.S. Government is taking over three Tylenol plants following a blizzard of drug recalls and a Food and Drug Administration criminal investigation into safety issues at
Read More

Japan Halts Vaccines After Deaths of Four Children

The Associated Press reports, Japan has temporarily stopped using vaccines from U.S. drugmaker Pfizer Inc. and Sanofi-Aventis SA of France while it investigates the deaths of four children who were
Read More